Find your path to Marco
144 people in our graph share verified history with Marco — schools, employers, funds. One of them is your warm intro.
Francesco De RubertisunlockedMarco: together at Medicxi (2024–2026)
×10Marco: together at Medicxi
Marco: together at Università degli Studi di Torino
About
Marco Prunotto brings hands-on bench-to-bedside experience from leading Roche's phenotypic drug discovery, nephrology and translational research teams, while serving as Full Professor and teaching scientists VC evaluation of translational value.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- MedicxiVenture Partnercurrent2024 — presentGenève, Suisse
- University of GenevaFull Professorcurrent2025 — present
- University of GenevaPrivat Docent (Senior Lecturer) - School of Pharmaceutical Sciences2018 — 2025Geneva Area, Switzerland
- RocheGlobal Head of Technology and Translational Research2021 — 2023Basel, Switzerland
- GalapagosHead of Translational Research2020 — 2021Basel, Basel-Town, Switzerland
- GenentechHead of I2O Innovation Office (Clinical Science Director)2018 — 2020Basel and San Francisco
- GenentechSenior Clinical Development Scientist2016 — 2018
- RochePhenotypic Drug Discovery & Target Identification Lead2013 — 2016Région de Basel, Suisse
- RocheRenal/Fibrosis Group lead (Principal Senior Scientist)2012 — 2013Région de Basel, Suisse
- RocheLaboratory Head (Principal Scientist)2010 — 2012Région de Basel, Suisse
- IRCCS Ospedale Pediatrico Giannina GasliniCell Biologist @ the Nephrology Department2008 — 2010Genoa Area, Italy
- University of GenevaPostdoctoral Fellow - - Pathology & Immunology Dept2004 — 2007Geneva Area, Switzerland
Skills & more
Artificial Intelligence (AI)2Artificial Neural Networks2Biology1Biochemistry16Biotechnology22Clinical Development12Cell17Drug Discovery49In Vitro36Life Sciences37In vitro8Molecular Biology15
+7 more
OncologyPharmaceutical IndustryPharmacologyCell BiologyCell CultureDrug DevelopmentImmunologyLanguages English · French · German · Italian
From Marco's professional profile.
Colleagues at Medicxi
Frequently asked questions
- Who is Marco Prunotto?
- Marco Prunotto brings hands-on bench-to-bedside experience from leading Roche's phenotypic drug discovery, nephrology and translational research teams, while serving as Full Professor and teaching scientists VC evaluation of translational value.
- Where does Marco Prunotto work?
- Marco Prunotto is Venture Partner at Medicxi.
- What does Marco Prunotto invest in?
- Marco Prunotto invests in Biotech, Digital Health, Healthtech, Medical Devices.
- Where did Marco Prunotto go to school?
- Marco Prunotto studied at Università degli Studi di Torino (Doctor of Philosophy (PhD) - College of Veterinary Medicine, Basic Science and Applied Veterinary Biotechnology); Università degli Studi di Torino (Master of Biology (Botany), Biology - Botany).
Same school
Also attended Università degli Studi di Torino67
Andrea Di CamilloFounder, CEO & Managing Partner at P101 VenturesStefano LomartireInvestment Executive at Apposite CapitalAndrea SilvelloBanking & Real Estate at Proximity CapitalFederico GaliziaIFC Vice President and Chief Risk Officer at International Finance CorporationAlberto CrestoGeneral Partner at Lunar VenturesGiovanni FabaroInvestment Associate at Oltre Impact
+ 61 more
Shared employers
Also worked at University of Geneva21
Hadrien BouchezPartner at Kurma PartnersVincent OssipowPartner at Omega FundsPeter DudekPresident at MRL Ventures FundMarc CikesManaging Director at Debiopharm Innovation FundKris KaczmarekInvestment Director at QDNL ParticipationsBenoit DubuisSwitzerland Board Member at MassChallenge Mexico
+ 15 more
Also worked at Roche229
Joe HorsmanInvestor at Madrona Venture GroupMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersCyndi ReseburgInvestor at Initialized CapitalNarges BaniasadiVenture Partner at Think+ Ventures Management, Llc
+ 223 more
Also worked at Galapagos17
Michele MantoVenture Partner at XGEN VentureHelmuth van EsAdvisory Committee member at Curie CapitalRianne EllenbroekPrincipal at BioGeneration VenturesPaul StoffelsVice President at Johnson & Johnson Innovation – JJDCRonald BrusFounder and Chief Growth Officer at Leyden LabsPierre RaboissonChief Executive Officer Chief Scientific Officer Co-founder at Coultreon
+ 11 more
Also worked at Genentech246
David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Logan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock Ventures
+ 240 more